QFIN Investor Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Qfin Holdings, Inc.

Qfin faces a securities class action alleging it misled investors about the impact of PRC regulatory changes after its Q2 2026 results showed revenue falling 31.6% YoY to RMB3.57 billion and net income plunging 76.8% to RMB401.4 million. The company also guided for a 67%-73% YoY decline in Q3 non-GAAP net income, citing higher funding costs and a Chinese consumer-credit liquidity shock. QFIN ADS fell $2.18, or 18.91%, to $9.35 on August 26 following the results and outlook.

Analysis

The litigation notice is not itself a fundamental catalyst; the investable signal is that QFIN's earnings reset appears to reflect a simultaneous squeeze in loan-funding availability, credit-risk capacity, and regulatory interpretation. That combination can impair platform economics nonlinearly: lower originations reduce fee revenue while higher funding costs and provisions consume the residual spread, making prior earnings multiples unreliable until management demonstrates stable funding and take rates. The tax item also introduces a separate risk that cash-tax normalization is structurally higher rather than a one-time charge.

Over the next 1-3 months, QFIN remains vulnerable to further estimate cuts as analysts translate weak forward profitability into a lower normalized ROE and potentially a higher China-regulatory discount rate. FINV and YRD are the most relevant read-through shorts/watch names, although their exposure should be differentiated by funding sources, on-balance-sheet credit risk, and borrower segment rather than treated as a blanket sector trade. A broad Chinese liquidity improvement could produce a sharp short-covering rally, but would not resolve QFIN-specific uncertainty around tax treatment and regulatory compliance.

The contrarian case is that the equity may already discount an extreme earnings trough if funding stress proves temporary and capital-light facilitation volumes recover. That thesis requires independently verifiable evidence—sequential improvement in funded volume, stable delinquency/vintage data, lower funding costs, and confirmation that the tax charge does not recur—rather than management commentary. The next results release is the key binary catalyst; absent those markers, the risk is a second leg down driven by guidance credibility rather than the lawsuit.

Key Decisions for Investors

• Maintain an underweight/short bias in QFIN for the next earnings cycle; initiate only on failed rallies toward the pre-guidance-reset trading range rather than chase post-drop weakness. Cover if management shows two consecutive months of improving funding spreads and reiterates a non-recurring tax treatment.
• Use a relative-value expression: short QFIN versus long FINV in modest size over 1-3 months, conditional on FINV demonstrating stable originations and credit metrics. The thesis is that QFIN carries greater earnings-quality and tax/regulatory uncertainty; exit if the QFIN/FINV relative spread retraces materially after verified funding normalization.
• Do not short the Chinese fintech basket indiscriminately. Set alerts for FINV and YRD guidance revisions, delinquency disclosures, and ABS/funding-market conditions; synchronized deterioration would justify expanding the sector hedge, while isolated QFIN weakness favors the single-name short.
• For long-only exposure, wait for the next quarterly release before considering QFIN. A potential tactical long is warranted only if sequential revenue stabilizes, funding costs decline, and management quantifies durable post-tax earnings power; without those disclosures, apparent low valuation is not a sufficient catalyst.